Biohaven Pharmaceutical Holding (BHVN) PT Raised to $156 at Piper Sandler
Tweet Send to a Friend
Piper Sandler analyst Tyler M. Van Buren raised the price target on Biohaven Pharmaceutical Holding (NYSE: BHVN) to $156.00 (from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
